India’s government nears the launch of a pivotal national policy aimed at fueling research, development, and innovation within the pharmaceutical and medical devices sectors, according to Union Health Minister Mansukh Mandaviya. Speaking at the G20 health ministers meeting in Gandhinagar, Mandaviya emphasized India’s healthcare vision, transitioning from volume-based approaches to a value-based leadership model. This initiative showcases India’s commitment to quality, accessibility, and affordability in healthcare, a commitment underscored during the COVID-19 pandemic.
Final Stages of National Policy Implementation
Union Health Minister Mansukh Mandaviya announced that India is on the verge of introducing a national policy focused on advancing research, development, and innovation in the pharmaceutical and medical devices sectors. This policy, which is in its concluding stages, aims to cultivate an environment conducive to innovation and progress within these critical domains.
Looking for Consultant?
Let’s have a word about your project
A Healthcare Vision for the Future
Mandaviya’s address to Indian industry leaders during the G20 health ministers meeting highlighted India’s aspiration for the future of healthcare. This vision revolves around a shift from conventional volume-based practices to a forward-looking value-based leadership model, embracing innovation and efficiency.
Unwavering Commitment to Quality and Accessibility
Mandaviya reiterated India’s unwavering dedication to ensuring quality, accessibility, and affordability in healthcare. The nation’s steadfast response to the challenges of the COVID-19 pandemic underscored its commitment to providing effective healthcare solutions.
Global Stage: G20 Health Ministers Meeting
Mandaviya’s remarks took place on the sidelines of the G20 health ministers meeting held in Gandhinagar from August 17-19. Indian industry leaders in pharmaceuticals, G20 ministers, and delegates were present, underscoring the significance of India’s initiatives on the global healthcare landscape.
Transitioning to Value-Based Leadership
India’s transition from traditional volume-based approaches to a value-based leadership model aligns with global trends in healthcare. This paradigm shift aims to optimize healthcare delivery by emphasizing value, effectiveness, and patient outcomes.
Fostering an Innovative Environment
Recognizing the paramount importance of research and development in healthcare advancement, Mandaviya highlighted India’s strides in fostering an innovative ecosystem. This proactive approach is poised to accelerate the pace of progress within the healthcare sector.
Collaboration: The Key to Success
Mandaviya invited collaboration from nations, industry leaders, healthcare professionals, and researchers, emphasizing that collective efforts are vital to elevate the pharmaceutical and medical devices sectors to new heights.
Global Acclaim for India's Excellence
Acknowledging India’s stature as a global hub for pharmaceutical excellence, international representatives at the G20 health minister’s meeting expressed interest in collaborating with India to harness its expertise.
Impactful Model: Jan Aushadhi Kendra:
India’s Jan Aushadhi Kendra initiative, providing accessible and affordable generic medicines and surgical equipment, garnered global attention. The success of this model has inspired other nations, including Indonesia, to consider its replication.
A Glimpse into the Future
With the imminent introduction of the national policy, India is poised for a groundbreaking leap in healthcare innovation. Operon Strategist commends the Indian government’s proactive approach and collaborative spirit, envisioning a brighter healthcare landscape for all.
How can Operon Strategist Help You?
Join Operon Strategist in embracing India’s visionary steps towards healthcare innovation. Let’s collaborate to elevate healthcare standards globally. Together, we can shape a brighter and more accessible healthcare future for all. Contact us today to be a part of this transformative journey.
